Navigation Links
Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology
Date:6/11/2008

nt candidate for the treatment of gout, is in preclinical development and is believed to be an inhibitor of the URAT1 transporter in the kidney, which is responsible for regulation of uric acid levels. We are evaluating our lead MEK inhibitor, RDEA119, in a Phase 1 study in advanced cancer patients, as well as in a Phase 1 study in normal healthy volunteers as a precursor to trials in patients with inflammatory diseases. Lastly, we have evaluated our second-generation MEK inhibitor for the treatment of cancer and inflammatory diseases, RDEA436, in a human micro-dose pharmacokinetic study and have selected it as a development candidate.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding our goals, including the expected properties and benefits of RDEA806, RDEA427, RDEA594, RDEA119, RDEA436 and our other compounds and the results of preclinical, clinical and other studies. Risks that contribute to the uncertain nature of the forward-looking statements include: risks related to the outcome of preclinical and clinical studies, risks related to regulatory approvals, delays in commencement of preclinical and clinical studies, and costs associated with our drug discovery and development programs and business development activities. These and other risks and uncertainties are described more fully in our most recently filed SEC documents, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, under the headings "Risk Factors." All forward-looking statements contained in this press release speak only as of the date on which they were made. We undertake no obligat
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
2. Ardea Presents Preclinical Data on Novel Next Generation Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating Potent Anti-HIV Activity Against Resistant Viruses
3. Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences
4. Ardea to Present at Cowen and Companys 28th Annual Health Care Conference
5. Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego
6. Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program
7. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
8. Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
9. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
10. Ardea Biosciences Announces $40 Million Private Placement
11. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... of a meter in size, are around us every ... health, as in some innovative early cancer treatments, but ... pollution, traffic emissions, cosmetics, sunscreen and electronics. , A ... led by Lan Yang, PhD, the Das Family Career ... their collaborators at Tsinghua University in China have developed ...
(Date:9/2/2014)... Sept. 2, 2014  TransCelerate BioPharma Inc. ("TransCelerate") ... approach for protecting personal data in Clinical Study ... and others. The document describes an approach to ... CSRs and other related clinical trial documents, and ... goal of the TransCelerate CSR Redaction approach is ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014  Xencor, ... biopharmaceutical company developing engineered monoclonal antibodies for the ... and cancer, today announced the appointment of ... development and the appointment of Lloyd Rowland ... general counsel. "Debra,s expertise in ...
(Date:9/2/2014)... Md. , Sept. 2, 2014  Spherix Incorporated ... and monetization of intellectual property, today announced that the ... patents to the Company in the month of August ... patents.  The issued patents are: ... , U.S.RE45,081 issued August 19, 2014; and , ...
Breaking Biology Technology:Engineers develop new sensor to detect tiny individual nanoparticles 2Engineers develop new sensor to detect tiny individual nanoparticles 3TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 2TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 3Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix 2
... connecting bones to muscles that raise an eyebrow or propel ... unusually forceful or awkward pull on the strings leaves us ... repair over 300,000 of these injuries every year, and doctors ... Using a combination of nanoscience and biomedical and civil engineering ...
... long a standard tool in biomedical research and diagnostic ... to new electronic biosensing technology developed by a team ... Institute of Technology. Essentially arrays of tiny test ... test multiple samples for their responses to chemicals, living ...
... Advisors LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today ... has denied Ramius, legitimate request for a list of the ... has launched a tender offer to purchase all of the ... in cash.  Ramius requested the stockholder list materials in accordance ...
Cached Biology Technology:The Achilles' heel of tendons 2The Achilles' heel of tendons 3Novel electronic biosensing technology could facilitate new era of personalized medicine 2Novel electronic biosensing technology could facilitate new era of personalized medicine 3Novel electronic biosensing technology could facilitate new era of personalized medicine 4Cypress Denies Ramius' Legal Right to Stockholder List Materials 2Cypress Denies Ramius' Legal Right to Stockholder List Materials 3
(Date:9/2/2014)... Museum will present the prestigious Parker/Gentry Award to Mr. ... biodiversity conservation awareness. The Parker/Gentry Award is given annually ... or organization whose efforts have had a significant impact ... actions can serve as a model to others. , ... science and conservation news website that draws more than ...
(Date:9/2/2014)... BETHESDA, MD The American Society of Human ... Institute (NHGRI), part of the National Institutes of ... School Science Teacher at The Wellington School in ... Fellow. The 16-month appointment begins today. , The ... early-career genetics professionals expand their skills, experience, and ...
(Date:9/2/2014)... It,s not always true that digital distribution of ... by physical means, at least when file sizes ... study published in Yale,s Journal of Industrial ... of games for consoles such as PlayStation3. Researchers ... caused lower greenhouse gas emissions than game files ...
Breaking Biology News(10 mins):ASHG and NHGRI award first genetics and education fellowship 2
... (NREL) is working with Ecopetrol, the largest oil company ... and palm oil harvesting into fuel ethanol for blending ... (CRADA) between NREL and Ecopetrol aims to optimize the ... the sugars are removed from the sugar cane) and ...
... WASHINGTON D.C. August 13, 2013 -- Adjacent to the walls of ... up our microcirculation -- there exists a peculiar thin layer of ... a few millionths of a meter thick, that layer is vital. ... the site of a cut and start the clotting process. ...
... brightly coloured crowns are better mothers than duller birds, according ... , Unlike humans, birds can see ultra-violet (UV) light. While ... us, to another bird it has the added dimension of ... also involved researchers from the University of California Davis, USA ...
Cached Biology News:NREL and Colombian oil firm unlocking agricultural waste feedstocks for biofuel 2NREL and Colombian oil firm unlocking agricultural waste feedstocks for biofuel 3Computer model predicts red blood cell flow 2Bright birds make good mothers 2
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni...
... is a high performance spectral scanning ... incubator. With the advanced SkanIt Software ... for drug discovery assay development. Varioskan ... intensity, time-resolved fluorescence and photometric assays ...
... series of refrigerated cold traps offers a ... low volatility/aqueous solvents or high volatility solvents. ... vacuum concentrators/centrifugal evaporators. Also used for maintaining ... as used in electron microscopes. Can be ...
Black 96 Well Plate EB, RE Bottom...
Biology Products: